Neurology Clinical Trials

Statistical methods in neurology trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All neurology trials

1,213 results

• PKUIndependent statistical analysis of Fluorodeoxyglucose Positron Emission Tomography (FDG PET) Findings in Patients With Phenylketonuria Before and After KUVAN Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 6NCT00986973
• PlaceboIndependent statistical analysis of Efficacy of Open Label Placebo in Children With FGIDs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02389998).Phase NAResults postedn = 31NCT02389998
• Placebo In Chronic Back Pain – Double-Blind Randomized Control Trial: Complete Statistical AnalysisIndependent statistical analysis of Placebo In Chronic Back Pain - Double-Blind Randomized Control Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02013427).Phase 4Results postedn = 82NCT02013427
• Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on QT/QTC Interval: Complete Statistical AnalysisIndependent statistical analysis of Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on QT/QTC Interval: primary endpoint results, effect estimate with confidence interval,…Phase 1Results postedn = 31NCT04821063
• Play Intervention for Dementia for Promoting Cognitive Function: A Feasibility Study: Complete Statistical AnalysisIndependent statistical analysis of Play Intervention for Dementia for Promoting Cognitive Function: A Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 30NCT02846415
• PNCAIndependent statistical analysis of Parent/Nurse Controlled Analgesia in the Neonatal Intensive Care Unit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01823497).Phase NAResults postedn = 36NCT01823497
• PNPIndependent statistical analysis of BlueWind Medical Reprieve System for the Treatment of PNP: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02062398).Phase NAResults postedn = 13NCT02062398
• POINTIndependent statistical analysis of Pediatric Oncology Nutrition Intervention Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06175273).Phase 2/3Results postedn = 20NCT06175273
• POINTIndependent statistical analysis of Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 3Results postedn = 4,881NCT00991029
• POLARIndependent statistical analysis of Acceptance and Performance of the CP1170 Sound Processor in Experienced Adult Cochlear Implant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 20NCT05619575
• PoNDIndependent statistical analysis of Prazosin and Cerebrospinal Fluid (CSF) Biomarkers in Mild Traumatic Brain Injury (mTBI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 4Results postedn = 9NCT03221751
• POSEIDON-2Independent statistical analysis of POSEIDON-2, a ClinicalTrials.gov study evaluating global impairment of health-related quality of life after status epilepticus in patients managed in the intensive care unit.n = 145NCT06100978
• POSITIVE Stroke Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of POSITIVE Stroke Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01852201).Phase NAResults postedn = 33NCT01852201
• Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels: Complete Statistical AnalysisIndependent statistical analysis of Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 3Results postedn = 203NCT01165554
• Postpartum Perineal Pain After Obstetric Anal Sphincter Injuries: Complete Statistical AnalysisIndependent statistical analysis of Postpartum Perineal Pain After Obstetric Anal Sphincter Injuries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03470675).Phase 4Results postedn = 67NCT03470675
• Poststroke Depression in Hemorrhagic Stroke: Complete Statistical AnalysisIndependent statistical analysis of Poststroke Depression in Hemorrhagic Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03826875).Phase 2Results postedn = 8NCT03826875
• POTS-GUTIndependent statistical analysis of Gastrointestinal Symptoms in Postural Orthostatic Tachycardia Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03263819).Phase NAResults postedn = 26NCT03263819
• Pramipexole Conversion to Ropinirole Controlled Release (CR): Complete Statistical AnalysisIndependent statistical analysis of Pramipexole Conversion to Ropinirole Controlled Release (CR): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00275275).Phase 3Results postedn = 61NCT00275275
• Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder: Complete Statistical AnalysisIndependent statistical analysis of Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00183430).Phase NAResults postedn = 20NCT00183430
• Precision Versus Endurance Training to Improve Walking After Chronic Incomplete SCI: Complete Statistical AnalysisIndependent statistical analysis of Precision Versus Endurance Training to Improve Walking After Chronic Incomplete SCI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 21NCT01765153
• Preemptive Analgesia With Celecoxib for Acute Dental Pain Management: Complete Statistical AnalysisIndependent statistical analysis of Preemptive Analgesia With Celecoxib for Acute Dental Pain Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04790812).Phase 4Results postedn = 65NCT04790812
• Preemptive Local Anesthesia in Vaginal Surgery: Complete Statistical AnalysisIndependent statistical analysis of Preemptive Local Anesthesia in Vaginal Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00318292).Phase 4Results postedn = 90NCT00318292
• Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel: Complete Statistical AnalysisIndependent statistical analysis of Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01637077).Phase 2Results postedn = 46NCT01637077
• Premenstrual Dysphoric Disorder and Antiepileptic Drugs: Complete Statistical AnalysisIndependent statistical analysis of Premenstrual Dysphoric Disorder and Antiepileptic Drugs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00612235).Phase NAResults postedn = 80NCT00612235
• PREMIERIndependent statistical analysis of Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 197NCT02186561
• Preoperative Acetaminophen and Carbohydrate Loading: Complete Statistical AnalysisIndependent statistical analysis of Preoperative Acetaminophen and Carbohydrate Loading: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03131713).Phase 3Results postedn = 101NCT03131713
• Preoperative IV Versus Oral Acetaminophen: Complete Statistical AnalysisIndependent statistical analysis of Preoperative IV Versus Oral Acetaminophen: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03468920).Phase 4Results postedn = 120NCT03468920
• PREVAILIndependent statistical analysis of A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain Associated With Post-Acute Sequelae of SARS-CoV-2 Infection: primary endpoint results,…Phase 2Results postedn = 63NCT05472090
• PREVENTIndependent statistical analysis of Protocol-guided Rapid Evaluation of Veterans Experiencing New Transient Neurological Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02769338).Phase NAResults postedn = 2,292NCT02769338
• Preventing Propofol-associated Injection Pain: Complete Statistical AnalysisIndependent statistical analysis of Preventing Propofol-associated Injection Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00864682).Phase 4Results postedn = 156NCT00864682
• Prevention of Bone Loss After Acute SCI by Zoledronic Acid: Complete Statistical AnalysisIndependent statistical analysis of Prevention of Bone Loss After Acute SCI by Zoledronic Acid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02325414).Phase 2Results postedn = 60NCT02325414
• Prevention of Musculoskeletal Injuries in Slovenian Armed Forces: Complete Statistical AnalysisIndependent statistical analysis of Prevention of Musculoskeletal Injuries in Slovenian Armed Forces: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03415464).Phase NAResults postedn = 160NCT03415464
• Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): Complete Statistical AnalysisIndependent statistical analysis of Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00602420).Phase 3Results postedn = 510NCT00602420
• PRIMEIndependent statistical analysis of Pain Reduction With Intranasal Medications for Extremity Injuries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02778880).Phase 3Results postedn = 90NCT02778880
• PRIMEIndependent statistical analysis of Prospective Research in Infants With Mild Encephalopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01747863).Phase NAResults postedn = 63NCT01747863
• Primed vs. Unprimed rTMS in Chronic Stroke: Complete Statistical AnalysisIndependent statistical analysis of Primed vs. Unprimed rTMS in Chronic Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01757821).Phase NAResults postedn = 11NCT01757821
• PRINTOJDMTRIndependent statistical analysis of Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00323960).Phase 3Results postedn = 139NCT00323960
• PRISMIndependent statistical analysis of Efficacy and Safety Study of I10E in Treatment of Patients With CIDP: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 3Results postedn = 44NCT02293460
• PRISMSIndependent statistical analysis of the PRISMS phase 3 trial of alteplase in participants with mild stroke, covering the Day 90 modified Rankin Scale endpoint, risk difference, odds ratios, safety outcomes, trial design,…Phase 3Results postedn = 313NCT02072226
• Programmed Intermittent Bolus Dosing Versus Continuous Epidural Infusion for Epidural Analgesia in Abdominal Surgery.: Complete Statistical AnalysisIndependent statistical analysis of Programmed Intermittent Bolus Dosing Versus Continuous Epidural Infusion for Epidural Analgesia in Abdominal Surgery.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 4Results postedn = 120NCT03307174
• PROGRESSIndependent statistical analysis of Factors Affecting Early Progress of Cochlear Implant Outcomes in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05265260).Phase NAResults postedn = 32NCT05265260
• Project SAVEIndependent statistical analysis of CBT-I on Alcohol Treatment Outcomes Among Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03806491).Phase NAResults postedn = 67NCT03806491
• PrometheusIndependent statistical analysis of Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DM: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 3Results postedn = 31NCT00651040
• PROMISE-2Independent statistical analysis of the PROMISE-2 phase 3 trial of ALD403 (eptinezumab) for the prevention of chronic migraine, including trial design, endpoints, ANCOVA, MMRM, Cochran-Mantel-Haenszel analyses, reported results, safety, and statistical interpretation.Phase 3Results postedn = 1,121NCT02974153
• Promotion of Physical Activity in Adolescents With Intellectual and Developmental Disabilities: Complete Statistical AnalysisIndependent statistical analysis of Promotion of Physical Activity in Adolescents With Intellectual and Developmental Disabilities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 116NCT03684512
• PROSEEK: A Phase 2 Study In Early Parkinson’s Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706: Complete Statistical AnalysisIndependent statistical analysis of PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706: primary endpoint results, effect estimate with…Phase 2Results postedn = 513NCT03655236
• Prospective Effectiveness and Safety Study of Cladribine in Participants Who Change First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS): Complete Statistical AnalysisIndependent statistical analysis of Prospective Effectiveness and Safety Study of Cladribine in Participants Who Change First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS): primary endpoint results, effect estimate with confidence interval, sample-size…Phase NAResults postedn = 256NCT04934800
• PROTECTED TAVRIndependent statistical analysis of PROTECTED TAVR, a randomized trial evaluating the Sentinel Cerebral Protection System during transcatheter aortic valve replacement and the rate of stroke through 72 hours or discharge.Phase NAResults postedn = 3,000NCT04149535
• PROTECTED TAVRIndependent statistical analysis of PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 3,000NCT04149535
• Protective Effects of Long-term Remote Limb Ischemic Preconditioning For Carotid Artery Stenting: Complete Statistical AnalysisIndependent statistical analysis of Protective Effects of Long-term Remote Limb Ischemic Preconditioning For Carotid Artery Stenting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 189NCT01654666

← All therapeutic areas